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Background:   The measurement of catecholamines and their metabolites in either urine or 
plasma is an important diagnostic test used to exclude the presence of neuroendocrine 
tumours.  Because of weak chromatographic retention and potential ion-suppression, reverse-
phase LC-MSMS is not ideal for analysis of these polar molecules. Here, we investigate 
derivatisation by ethylation as an alternative approach. 
Methods:   A simple and rapid method involving acetaldehyde and a reducing agent was used to 
convert urine free metanephrines and catecholamines, and their deuterated analogues as 
internal standards, to mono-ethyl or diethyl- derivatives.  Using an Agilent 6460 triple-
quadrupole mass spectrometer, precursor and product ion mass spectra were recorded to 
allow comparison of multiple reaction monitoring methods for both derivatised and non-
derivatised analytes under reverse-phase LC-MSMS conditions with positive electrospray 
ionization. 
Results:   Conversion of biogenic amines to less polar ethyl derivatives increased their mass and 
enhanced the intensity of their molecular ions and fragments.  Ethylation also improved the 
chromatographic properties of the amines, with greater retention and elution from reverse-
phase HPLC columns with a methanol or acetonitrile gradient.  The signal response of tandem 
mass spectrometric detection was increased up to 50-fold for ethyl metanephrines compared 
to non-derivatised compounds.  This increase allowed for the omission of solid-phase extraction 
of urine as a clean-up step prior to analysis. The ‘dilute-derivatise-shoot’ method maintained 
analytical performance with respect to between-run imprecision (CV < 6 %) and accuracy in an 
external quality assurance program. Gender-related ranges for free metanephrines in early-
morning spot urines, collected from adult patients, were similar using either derivatised or non-
derivatised samples.   
Conclusions:   The LC-MSMS detection of free urine biogenic amines can be greatly enhanced by 
ethyl derivatisation, which is easy and rapid to perform.   Advantages include improved 
chromatography and lower limits of quantitation, that negate the requirement for solid-phase 
clean-up of urine prior to analysis. A disadvantage is the potential toxicity of the derivatising 








1.  Introduction 
 
The biochemical investigation of the neuroendocrine tumours phaeochromocytoma or 
paraganglioma (PPGL) involves the measurement of catecholamines and their metabolites, in 
particular the metanephrines [1, 2].  Free metanephrines in plasma are now regarded to have 
the highest clinical sensitivity, compared to other analytes, in excluding a diagnosis of 
phaeochromocytoma, and are recommended for first-line testing [3-5].  Total (i.e., free plus 
conjugated) urinary metanephrines in a 24-hour collection are also a recommended test [5].  
Although not favored in clinical practice guidelines, urinary and plasma catecholamines are still 
requested in the investigation of hypertension [6,7].   
 
For the measurement of biogenic amines, laboratories use high-pressure liquid 
chromatography to separate individual metanephrines and catecholamines prior to 
quantitation.  With the increasing availability of bench-top tandem mass spectrometers (MSMS) 
in the clinical laboratory, these instruments are replacing electrochemical detectors to provide 
more specific and robust analysis of biogenic amines for all specimen types [8-12].   LC-MSMS 
has the advantage of profiling related analytes so that simultaneous determination of free 
metanephrines and free catecholamines from urine is possible [9, 13].  These profiling methods 
may become increasingly useful given emerging evidence suggesting that urinary free 
metanephrine analysis may be the most sensitive test for screening patients for PPGL [13-15]. 
 
Chemical derivatisation has been used in quantitative mass spectrometry of small 
molecules to increase the sensitivity required for various applications [16].  Some specific 
examples for clinical purposes are the conversion of testosterone to an oxime derivative to 
allow the determination of the low nanomolar serum concentrations found in females and 
young children [17], and the derivatisation of vitamin D and its metabolites to enable 
measurement of 1,25-dihydroxy-vitamin D3 in serum [18].  It has been reported that ethylation-
labeling of amino groups on monoamine neurotransmitters, such as noradrenaline, dopamine 
and serotonin, greatly increases the sensitivity of tandem mass spectrometric detection in brain 
micro-dialysate solutions [19].   Although biogenic amines are normally measured by LC-MSMS 




for reverse-phase LC-MSMS, and many laboratories are using HILIC chromatography for their 
analysis [20, 21].  In this study, we investigate the reverse-phase chromatographic and mass 
spectrometric properties of ethylated derivatives of metanephrines and catecholamines, and 
present a rapid LC-MSMS method for their direct quantitation in diluted urine that could be 
used in the clinical laboratory.  
 
2.  Materials and methods 
 
2.1 Chemicals and reagents 
 
Noradrenaline bi-tartrate, adrenaline bi-tartrate, dopamine HCl, normetanephrine HCl, 
3-methoxytyramine HCl and d4-acetaldehyde were purchased from Sigma-Aldrich Australia.  
Metanephrine HCl was purchased from Prime Organics Inc, USA.  Deuterated internal standards 
were purchased from CDN Isotopes via SciVac Australia and included: (±)-noradrenaline-
2,5,6,α,β,β-d6 HCl, (±)-adrenaline-2,5,6,α,β,β-d6 HCl, (±)-adrenaline-d3 (N-methyl-d3), 
dopamine-d4  [2-(3,4-dihydroxyphenyl)ethyl-1,1,2,2-d4-amine HCl],  (±)-normetanephrine-
α,β,β-d3 HCl, (±)-metanephrine-d3 HCl (N-methyl-d3)  and 2-(4-hydroxy-3-hydroxy-3-
methoxyphenyl)ethyl-1,1,2,2-d4-amine HCl. The water used was high purity reverse osmosis, 
organic-filtered, 0.22 µm-filtered (‘MilliQ’, Millipore, Bedford, MA, USA). Methanol and 
acetonitrile (Mallinkrodt) were chromatography grade and ammonium acetate, formic acid, 
cyanoborohydride coupling buffer (Sigma-Aldrich, Australia) and acetaldehyde (BDH Chemicals, 
Australia) were analytical grade.   
2.2 Preparation of calibrators, internal standards and quality controls 
Standard solutions of each biogenic amine (i.e., noradrenaline, adrenaline, dopamine, 
normetanephrine, metanephrine and 3-methoxytyramine) were prepared as solutions of 
weighed material dissolved in 1% formic acid, and stored frozen at minus 70
o
C. 
Standard stock solutions were diluted using 1% formic acid and mixed to create a working stock 
of each analyte at a concentration of 10 µg/mL. Calibration standards were prepared in 1% 
formic acid from this working stock by serial dilution across a concentration range of 0.005 to 
100 ng/mL.  
The deuterated internal standards for each of the catecholamines (i.e., adrenaline, 
noradrenaline and dopamine) and the metanephrines (i.e., metanephrine, normetanephrine 




stock mixed solution containing all internal standards at 1 µg/mL each (IS Mix) was prepared by 
dilution of the stock solutions in 1% formic acid. 
Quality control samples included LyphoCheck Quantitative Urine Controls ‘Normal’ and 
‘Abnormal’ (Lyphocheck, BioRad Laboratories, Australia, Cat # 376 and 377 respectively) and 
were prepared as per the manufacturer’s instructions. Additional QC materials included pooled 
patient urine (aliquoted and stored frozen) used as a low QC, and surplus urine samples from 
an external quality assurance program of  the Royal College of Pathologists of Australasia 
(RCPA) were utilized as high QC material.  QC materials were not subjected to acid hydrolysis, 
so that only free urine metanephrines were measured and target concentrations were assigned 
in-house. External quality assurance materials for urine biogenic amines were purchased from 
RCPAQAP Pty Ltd (Sydney, Australia).   
2.3 Collection and preparation of urine samples 
Early morning spot urine samples were collected after overnight rest prior to 10 am 
from 198 adults (age range 23-91; 108 males, 90 females) being tested for urine albumin as part 
of routine care. The pH was measured (mean 5.9, range 4.5 to 9.0) , but no stabilisers or acid 
were added.  Urine creatinine was measured enzymatically on a Cobas c702 analyser (Roche 
Diagnostics, Australia).  All specimens were stored frozen at minus 15°C prior to processing by 
batch analysis.  Samples were anonymised to the researchers at point of access and the study 
complied with the Declaration of Helsinki on ethical principles for medical research. 
Urine free metanephrines and catecholamines were measured simultaneously following 
solid phase extraction (SPE) without prior derivatisation. In addition, samples were directly 
analysed following dilution and derivatisation without the use of SPE.     
For analysis with SPE, urine (100 μL) was equilibrated with 50 μL of IS Mix.   Biogenic 
amines were then complexed with boronate at pH 9 [9], before undergoing SPE (Versaplate 
Plexa, Agilent Technologies) and elution into a 96-well plate with formic acid for LC-MSMS 
quantitation without derivatisation. 
For analysis without SPE, urine samples (50 µL) were equilibrated with 20 µL IS Mix and 
diluted with 1.0% formic acid to a total volume of 1.0 mL with brief vortex-mixing.  Diluted 
urine (80 µL) was derivatised after the sequential addition of 1.0 M acetate buffer pH 5 (20 µL), 
3.0 g/L cyanoborohydride buffer (40 µL), and 20% acetaldehyde solution (20 µL) as described by 




silicon mat. The reductive amination of primary amines (i.e., noradrenaline, normetanephrine, 
dopamine and 3-methoxytyramine) produces diethyl-derivatives, whereas that of secondary 
amines (i.e., adrenaline and metanephrine) results in monoethyl-derivatives [19].  Post 
incubation, the plate was transferred to an autosampler held at 6°C for analysis by LC-MSMS.   
2.4 Chromatography 
Chromatography was performed using Agilent 1200 Infinity HPLC modules with binary 
pump, autosampler and thermostatted column compartment (Agilent Technologies, Mulgrave, 
Australia).  After SPE clean-up, non-derivatised samples were injected (20 µL) onto a Kinetex F5 
column  (100 mm x 3.0 mm; 2.6 µm core-shell packing, Phenomenex Australia) using a 0.3 
mL/min mobile phase of 2 % methanol in 0.2 % formic acid for 1 minute, followed by a linear 2 
– 80 % methanol gradient over 3 minutes, held at 80 % methanol for 0.3 minutes and re-
equilibrated to 2 % methanol in 0.2 % formic acid.  Total run time was 6.2 minutes.  Derivatised 
samples that were prepared without SPE were injected (5 µL) onto a reversed phase column 
(Atlantis T3 150 mm x 2.1 mm; 3 µm packing, Waters Australia) using a 0.2 mL/min flow of 
mobile phase delivering a linear acetonitrile gradient (4 - 24 % over 5 minutes with 3 minutes 
re-equilibration) in 0.2 % formic acid.  Total run time was 11 minutes.  No harmful effects of 
residual derivatisation agents were observed on column lifetime or performance. 
2.5 Mass spectrometry 
Tandem mass spectrometric detection was performed using an Agilent 6460 series 
instrument with jet stream technology (Agilent Technologies, Australia).  Electrospray ionization 
was used in positive ion mode at unit mass resolution. Optimized detector settings for voltages, 
gas temperatures and flows are listed in Table 1. The ion source was regularly cleaned, and the 
check and auto-tune features of the MassHunter software were used to maintain mass 
accuracy of the instrument over time with electrospray tuning mix (Agilent Technologies, Santa 
Clara, USA). 
2.6 Data analysis 
Data were stored in Microsoft Excel spreadsheets and statistical analyses carried out 
using Analyse-It (Version 2.22).  Comparisons of means were performed using the t-test, and 
ranges were determined as 95
th
 percentile ranges of log-transformed data distributions.  






3.  Results 
 
3.1 Mass spectrometer tuning for non-derivatised and derivatised biogenic amines 
Optimized multiple reaction monitoring (MRM) parameters for monitoring non-
derivatised catecholamines and metanephrines, and their ethyl-derivatives formed by reaction, 
either with unlabeled acetaldehyde or D4-acetaldehyde, are shown in Table 1 for the Agilent 
6460 triple quadrupole mass spectrometer.  Also shown are the same parameters for their 
deuterated internal standards.  In their original publication, Ji et al. [19] compared different 
aldehydes for their performance characteristics in the assay of monamine neurotransmitters in 
rat brain micro dialysates.  By using formaldehyde or acetaldehyde with one, three or four 
isotopic atoms, derivatives of different masses were produced and assessed for possible 
interference peaks and low background noise.  Although they selected D4-acetaldehyde as the 
ethyl donor, unlabelled acetaldehyde is cheaper and more readily available, and was used for 
the majority of the present work. 
From Table 1, there are two features of the mass spectrometric properties of biogenic 
amines that should be noted.  First, the loss of water occurs readily and can be induced in-
source in the production of precursor ions, or in the collision cell at low energy in the formation 
of product ions.  Although not highly specific, MRM transitions involving water loss do give rise 
to intense product ions which can be useful for sensitive quantitation, provided that they are 
free from interferences. Second, isobars exist that require chromatographic separation of 
adrenaline and normetanephrine when not derivatised (e.g., 184>166).  The ethylation of these 
biogenic amines with acetaldehyde removes this isobaric pair, but introduces a new pair with 
noradrenaline and metanephrine (226>208).  This does not occur if D4-acetaldehyde is used, 
due to the formation of diethyl and monoethyl-derivatives with different masses, and thus 






3.2     Chromatographic profiles of non-derivatised and derivatised biogenic amines 
 The HPLC profiles of catecholamine and metanephrine internal standards on a core-shell 
reverse-phase column promoted for polar molecule retention (Phenomenex Kinetex F5) are 
shown in Figure 1, with elution using a methanol gradient.  Before derivatisation, all 6 analytes 
were well separated under the conditions used and the order of elution between 1.6 and 4.0 
minutes was: noradrenaline, adrenaline, normetanephrine, dopamine, metanephrine and 3-
MT.  Due to their polar nature, noradrenaline and adrenaline were poorly retained on the 
column, even with the starting aqueous mobile phase of 0.2% formic acid containing only 2% 
methanol.   
 After conversion to ethyl derivatives with deuterated acetaldehyde, both catecholamine 
and metanephrine internal standards showed much greater retention on the column, as shown 
in Figure 1.  With the same methanol elution gradient (2-80%) as used for non-derivatised 
Table 1.
Agilent 6460 QQQ Mass Spectrometry Conditions for MRM Transitions of Non-derivatized and Ethyl-Labeled Catecholamines
and Metanephrines, and their Deuterated Internal Standards.
Reaction with unlabelled acetaldehyde increased mass units by 28 for mono-ethyl and 56 for di-ethyl derivatives.  
If d4-acetaldehyde was used, mass increases were 32 for mono-ethyl and 64 for di-ethyl derivatives. 
Precursor Ions Product Ions Dwell Fragmentor Collision Cell Accel
Compound Time Potential Energy Voltage
[m/z] [m/z] [msec] [V] [V] [V]
Non-derivatized Noradrenaline 170, 152* 152, 107 30 65, 100 20, 15 5
Adrenaline 184 166, 107 30 70 8, 24 5
Gas Temp 325 
o
C Dopamine 154 137, 91 30 75 8, 28 3
Gas Flow  5 L/min Normetanephrine 166* 134, 106 30 105 16, 20 3
Nebulizer  35  psi Metanephrine 180* 165, 148 30 120 16 5
Sheath Gas Temp 375 
o
C 3-MT 151* 119, 91 30 135 12, 20 3
Sheath Gas flow  12 L/min Internal Standards
Capillary   3000 V D6-Noradrenaline 176 158 30 65 4 5
D6-Adrenaline 190 172, 112 30 70 8, 24 5
D4-Dopamine 158 141 30 75 8 3
D3-Normetanephrine 169 109 30 105 20 3
D3-Metanephrine 183 168 30 120 16 5
D4-3MT 155 95 30 135 24 3
Derivatised Noradrenaline - diethyl 226 208, 179 20 90 10, 20 2
[reductive amination with acetaldehyde] Adrenaline - monoethyl 212 194, 150 20 70 18, 25 4
Dopamine - diethyl 210 137, 119 20 100 15, 25 2
Gas Temp 300 
o
C Normetanephrine - diethyl 240 222, 207 20 80 8, 20 2
Gas Flow  9 L/min Metanephrine - monoethyl 226, 208* 208, 193 20 90, 140 10, 18 2
Nebulizer  60  psi 3-MT  - diethyl 224 151, 119 20 100 12, 25 5
Sheath Gas Temp 400 
o
C Internal Standards
Sheath Gas flow  12 L/min D6-Noradrenaline - diethyl 232 214, 185 20 90 10, 20 2
Capillary   3000 V D3-Adrenaline - monoethyl 215 197, 153 20 70 18 4
D4-Dopamine - diethyl 214 141, 123 20 100 15, 25 2
D3-Normetanephrine - diethyl 243 225, 210 20 80 8, 20 2
D3-Metanephrine - monoethyl 229, 211* 211, 196 20 80, 140 10, 18 2
D4-3MT - diethyl 228 155, 123 20 100 12, 25 5




amines, the order of elution between 3.3 and 4.6 minutes was altered to: adrenaline, 
noradrenaline, metanephrine, dopamine, normetanephrine and 3-MT.  The change in retention 
order was because the primary amines formed less polar di-ethyl derivatives, whereas 
secondary amines formed mono-ethyl derivatives with relatively less affinity for the HPLC 
stationary phase.  Under the HPLC gradient conditions used, di-ethyl derivatisation increased 
the retention times of noradrenaline and normetanephrine by 2.3 and 1.6 minutes, 
respectively, whereas mono-ethyl derivatization only increased retention times for adrenaline 
and metanephrine by 1.3 and 0.3 minutes, respectively.  Nevertheless, all ethyl derivatives 
were retained on the HPLC column under starting mobile phase conditions of 2% methanol, and 
could be eluted as sharp peaks by increasing the methanol concentration in the mobile phase. 
Similar improved retention and separation using the ethyl derivatives was obtained using a 
Waters Atlantis T3 column (150 x 2.1 mm, 3µm packing) and an acetonitrile gradient (4% to 
24% over 5 minutes plus 3 minutes re-equilibration), with elution occurring in the same order 
and a run time of 9 minutes.  
As well as showing improved chromatographic properties, the derivatised biogenic 
amines were detected with much greater sensitivity by the tandem mass spectrometer.  For 
example, with the mass transitions shown in Figure 1, peak heights per pmol of analyte injected 
onto the HPLC column for normetanephrine, metanephrine and 3-MT were 50, 13 and 4 times 
higher, respectively, after ethylation, with similar low levels of background noise.  This large 
increase in signal-to-noise ratio is not unlike that found in the original report where ethylation 
derivatization was used in the analysis of monoamine neurotransmitters in rat brain micro-






Figure 1 Chromatography profile of catecholamines and metanephrines before (upper 
panel) and after (lower panel) reductive amination to form mono-ethyl and di-ethyl derivatives.  
Mixtures of 6 amines were injected onto a Kinetex F5 core-shell column (100 x 3 mm) at a flow 
rate of 300 uL/min and a 2 to 80% methanol gradient was used to elute compounds, which 










3.3 Free metanephrines in spot urines measured before and after conversion to ethyl derivatives 
 Due to an interest in early-morning spot urines as alternative specimens to 24-hour 
acidified urine collections, and free instead of total (i.e., free plus conjugated)metanephrines as 
alternative analytes for PPGL screening, a group of 198 spot urines were analysed from patients 
without known PPGL. The urine sample pH range was between 4.5 and 9.0, with 94% of the  
urines having a pH < 7.  To avoid any possible hydrolysis of conjugated metanephrines during 
urine storage, no acid preservative was used.   
The urines in this reference group were first subjected to biogenic amine profiling by LC-
MSMS of non-derivatised samples after SPE clean-up of boronate complexes using a previously 
validated method [9].  An example of ion chromatograms obtained from a patient urine is 
shown in Supplementary Figure 1.  A commercial urine quality control material was used at two 
levels to monitor assay performance, and the between-run assay imprecision is shown in Figure 
2.  For non-derivatised samples, the coefficients of variation for free metanephrines were less 




Figure  2 Inter-run imprecision (% C.V.) in the measurement of urine free metanephrines 
and catecholamines with (red bars) and without (blue bars) derivatisation at two QC levels.  
Concentrations in nmol/L in level 1 (solid bars) and level 2 (dotted bars) QC materials were 
normetanephrine (NMT) 1350, 7300;  metanephrine (MET)  370, 2870;  3-methoxytyramine 
















Level 1 - Not Derivatised
Level 1 - Derivatised
Level 2 - Not Derivatised




 In a study of the excretion of free biogenic amines using 24-hour urine collections, males 
were found to excrete significantly higher amounts per day than females [13].  For the present 
study, biogenic amine concentrations were converted to µmol/mol creatinine to take into 
account variability in spot urine concentrations.  Ranges obtained for free urine metanephrines 
are summarised in Table 2a when analysed without derivatisation.  Although median urine 
concentrations of biogenic amines (nmol/L) in males tended to be higher than in females, after 
normalisation for urine creatinine,  ranges for females were higher for females than males, 
especially for normetanephrine and 3-methoxytyramine.  Normalised urine concentrations of 
free metanephrines also appeared to be higher in adults over 60 compared to adults under 60 
years old, but this difference did not reach statistical significance in this group.  Ranges for 
females were consistently wider than for males and reached higher upper limits of normal, due 
principally to the lower creatinine concentrations in female urine. 
 
Males  (n=108) Females  (n=90) M vs F 
Mean Range Mean Range P 
a.  Not Derivatised 
Normetanephrine 10 4 - 20 14 5 - 31 0.0003 
Metanephrine 6 2 - 14 7 2 - 20 0.08 
3-Methoxytyramine 14 6 - 28 21 8 - 42 0.0003 
b.  Derivatised 
Normetanephrine 9 3 - 21 11 4 - 26 0.078 
Metanephrine 5 2 - 13 6 1 - 18 0.37 
3-Methoxytyramine 14 6 - 29 19 9 - 37 0.0001 
 
 
Table  2.    Urine free metanephrine concentrations according to gender, as determined from 
analysis of a group of 198 early morning spot urines, before and after derivatisation. 
Concentrations expressed as µmol/mol creatinine are shown as means and 95th percentile 
ranges of normal distributions of log-transformed data.  P values represent the statistical 








The early-morning adult spot urine samples were also analysed for free biogenic amine 
concentrations using a ‘dilute, derivatise and shoot’ approach.  As described in Materials and 
Methods, diluted non-acidified urines plus internal standards were subjected to ethylation with 
unlabeled acetaldehyde in sealed 96-well plates, which were then placed onto the LC-MSMS 
autosampler for direct injection and analysis.  Under these conditions, derivatised samples 
were stable for at least 72 hours (data not shown).  An example of ion chromatograms obtained 
from a patient urine is shown in Supplementary Figure 2.   
From the analysis of the same urine QC material as used for non-derivatised samples, 
between-run imprecision data are included in Figure 2.  The coefficients of variation (CV) for 
free normetanephrine and metanephrine were < 3% for derivatised samples, while values were 
higher at < 6% for noradrenaline and adrenaline.  When compared to non-derivatised samples, 
the imprecision data were similar, except for level 1 free 3-MT and dopamine, with CV around 
10% being reduced to below 5% by derivatisation. 
LC-MSMS analysis of diluted and derivatised urines produced similar concentrations of 
free biogenic amines to SPE-treated, non-derivatised urines, as shown in the 6 scatter plots in 
Figure 3.  The slopes of Passing-Bablok regression lines were close to 1.00 for all 6 analytes with 
few outliers, which did not affect the non-parametric statistical analysis.  The most scatter was 
observed for free adrenaline, but this analyte had the lowest concentration with all urine 
samples < 120 nmol/L, and most samples < 30 nmol/L. 
  Free metanephrine concentrations in derivatised spot urines are shown in Table 2b for 
males and females. While the mean free normetanephrine concentration in females was no 
longer significantly higher than for males, the overall ranges of results were similar for 
concentrations estimated from derivatised and non-derivatised urine samples, with no 
statistically significant differences between the two methods.  
 Ion suppression effects were assessed by the comparison of the peak areas of ethylated 
internal standards in derivatised patient urine samples with peak areas from non-matrix 
standard injections. The mean recoveries were 76 %, 68 % and 67 % for normetanephrine, 
metanephrine and 3-methoxytyramine respectively (n = 200 and CV <10 % for each analyte) 








Figure 3.     Scatter plots for free urine catecholamine and metanephrine concentrations, as 
measured in nmol/L in 198 early-morning spot urines by LC-MSMS with (y-axis) and without 
(x-axis) derivatisation.   
Non-parametric Passing-Bablok  regression equations for lines of fit are shown for each of the 6 
biogenic amines, and were not influenced by the outlier urine with high concentrations of 











3.4 Comparative method performance in an EQA program 
An external quality assurance (EQA) program of the RCPA provided more evidence that 
the two LC-MSMS methods for profiling biogenic amines in urine produced similar results.  This 
EQA program releases 12 urine samples over 6 months with random duplicates to allow 
imprecision to be calculated as SD, along with the bias from target concentrations.  In Figure 4, 
method performance is expressed as total error (2 SD + bias) divided by the allowable limit of 
performance as set by the RCPA.  A ratio less than 1.0 is considered desirable for each analyte 
in this EQA program. For all 6 biogenic amines, the ratios were less than 1.5 with most less than 
1.0, and were similar between non-derivatised and derivatised samples.  Urine noradrenaline 
had the worst performance value, and total error exceeded its allowable limit of performance 
by both methods. Urine metanephrines for EQA samples were analysed after an acid hydrolysis 
step, since the target concentrations provided in the EQA program were for total(i.e., free plus 
conjugated) urine metanephrine concentrations. 
 
Figure  4.    Performance summary for cycle 63 of the urine biogenic amines external quality 
assurance program of RCPAQAP. 
Comparative performance in the analysis of 12 urine samples over 6 months is shown for 
normetanephrine (NMT), metanephrine (MET), 3-methoxytyramine (3MT), noradrenaline 
(NAD), adrenaline (ADR) and dopamine (DOP) without (ND-solid bars) and with (D-striped bars) 
derivatisation.  The 2 SD of the analyses is represented by blue bars and the bias fraction by red 
bars.  The sum of the 2SD and bias components are divided by the allowable limits of 




















4.  Discussion 
 
The present work describes the use of ethylated derivatives for the LC-MSMS analysis of 
biogenic amines in urine in the clinical laboratory, in particular for rapid profiling of free 
metanephrines and catecholamines in diluted spot urine samples.  Derivatisation of these 
analytes improved their reverse-phase chromatographic performance and decreased their 
limits of quantitation, which in turn allowed the replacement of multi-step SPE sample 
preparation with a simple ‘dilute, derivatise and shoot’ approach. 
 Our work illustrates that, while not common in LC-MSMS, derivatisation can provide 
benefits to offset the work required for this additional procedural step. The general principles 
of derivatisation and reactions according to functional chemical groups have been reviewed by 
Xu et al. [16].  For primary and secondary amine groups, acylation reagents have been used to 
form amide derivatives.  However, in our work, a simple and rapid reductive ethylation 
procedure, which was first described by Ji et al. [19] to measure monoamine neurotransmitters 
in rat brain dialysates, has been applied.  These authors further exploited the use of these 
stable ethyl derivatives in the development of a method for measuring plasma catecholamines 
[22, 23], and brief reports by others, including our group, have appeared describing their use to 
enhance measurement of plasma free metanephrines [24] and urine biogenic amines [25]. 
In clinical chemistry, a major reason to consider a derivatisation step in LC-MSMS is to 
increase measurement sensitivity for analytes that are present in plasma at low concentrations.  
For example, Kushnir et al. [17] converted testosterone in plasma collected from women and 
children to an oxime derivative and found a lower limit of quantification of 35 pmol/L.  This 
limit was reduced a further 10-fold with a novel quaternary amino-oxy (QAO) reagent that is 
available commercially as Amplifex Keto reagent [26].  1,25-Dihydroxy-vitamin D is another low-
concentration analyte that has been measured by LC-MSMS following sample derivatisation, 
particularly with 1,2,4-triazoline-3,5-dione (TAD)-based reagents.  In this case, another 
commercially-developed reagent ,Amplifex Diene, was found to significantly enhance 
ionisation, and lower the limits of detection in plasma to 5 pmol/L [27].  Increased detection 
sensitivity may vary widely between analytes and derivatives, which can be explained by 




and reduced matrix interference following derivatisation.  For metanephrines, an increased 
detection sensitivity of nearly 100-fold has been reported for normetanephrine [19], and 
between 6- and 34-fold for free metanephrines [24], as is also found in the present work. 
While detection sensitivity is not of crucial importance in analysis of the relatively high 
concentrations of catecholamines and metanephrines present in human urine, the use of ethyl 
derivatives allows their direct measurement in diluted samples without the need for SPE clean-
up of urine.  Of the methods published to date that profile non-derivatised urinary 
catecholamines and metanephrines by LC-MSMS, all use SPE, either in reverse-phase mode of 
di-phenylboronate complexes at pH 9 [9, 28], or in weak cation-exchange format at pH 6.5 [13, 
29].  Ethylation allows a ‘dilute, derivatise and shoot’ approach for the measurement of free 
urinary biogenic amines.  This method, when compared to offline SPE approaches, reduces the 
sample preparation time, the number of overall steps involved, the solvent and sample volumes 
used, as well as the cost and risk of errors associated with the sample preparation. It is 
consistent with the requirements of modern sample preparation techniques associated with 
bioanalytical LC-MSMS, as identified by Nováková [30].  However, care must be taken to work 
in a fume hood or use sealed containers, because sodium cyanoborohydride is a highly toxic 
chemical that will produce hydrogen cyanide gas if exposed to strong acid.   
In the case of urinary biogenic amines, derivatisation also has chromatographic benefits.  By 
increasing analyte hydrophobicity, chromatographic retention and separation using reverse-
phase HPLC conditions is markedly improved.  This approach is preferable to using HILIC 
chromatography for polar molecules, as analyte separation can be difficult on HILIC columns 
and interferences due to isobars or cross-talk of ions in the mass spectrometer have been 
reported [31, 32]. 
Ion suppression effects were evident when evaluated by assessment of the recoveries of 
isotope-labeled internal standards. The mean recoveries for metanephrines of around 70 %  
with a CV < 10 % were considered reasonable for patient urines that contained varying levels of 
normetanephrine, metanephrine and 3-methoxytyramine and other matrix components. 
Despite signal suppression, the use of co-eluting labelled internal standards for each analyte 
compensated for these effects with respect to quantitation accuracy. Additional inherent 
features of the method that were designed to reduce ion suppression included the extensive 




When screening for the neuroendocrine tumours phaeochromocytoma and paraganglioma, 
the expert-recommended tests are plasma free metanephrines, or total (i.e., free plus 
conjugated) metanephrine excretion from a 24-hour urine collection [5, 33].  Nevertheless, it 
has been recognised that in practice many blood and urine specimens are not collected under 
proper conditions, thus limiting the utility of these tests.  A suggestion has been made that free 
metanephrines in early-morning spot urine may be the best test in the future from the 
perspective of both the patient and the laboratory [33].  With this in mind,  ranges for free 
metanephrine concentrations in adult spot urines have been determined in the present study: 
first, as non-derivatised samples after SPE clean-up, and then as ethyl derivatives without 
preliminary SPE.  Because there was very good agreement between the LC-MSMS analysis of 
both types of sample, the concentration ranges in the reference group urines were not 
significantly different.  There are limited data available in adults to compare the ranges for free 
urine metanephrines in spot samples when expressed as µmol/mol creatinine, but similar 
values have been published recently for normetanephrine and metanephrine [28].  To assist in 
the diagnosis of neuroblastoma in children, age-related decision limits have been published for 
free urine catecholamines, metanephrines and their metabolites measured by HPLC with 
electrochemical detection [34]. The adult ranges determined in the present study should be of 
value in evaluating the diagnostic performance of early-morning spot urine free metanephrines 
in screening for phaeochromocytoma and paraganglioma.  For simultaneous measurement of 
free catecholamines and metanephrines, spot urines should be collected with citric acid to 
produce a pH between 4 and 5, or be frozen immediately, since these conditions have been 
shown to stabilise free biogenic amines prior to LC-MSMS analysis [35]. 
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Supplementary  Information 
 
Supp. Figure 1.   Example extracted ion chromatograms of non-derivatised biogenic amines 
after SPE of a patient urine.  Concentrations of free catecholamines and metanephrines are 
as shown, and were obtained using quantifier MRM ion transitions for individual analytes as 
follows: Noradrenaline 152>107, adrenaline 184>107, dopamine 154>137, 
normetanephrine 166>134, metanephrine 180>165, and 3-methoxytyramine  151>91.    
 A  Kinetex F5 core-shell HPLC column (100 x 3 mm; Phenomenex) was used to separate the 

























































Noradrenaline  175  nmol/L  
Adrenaline  15  nmol/L   
Dopamine  756  nmol/L   
Free normetanephrine  75 nmol/L   
Free metanephrine  38 nmol/L  




Supp. Figure 2.  Example extracted ion chromatograms of biogenic amines after dilution and 
derivatisation of a patient urine.  Concentrations of free catecholamines and metanephrines are 
as indicated, and were obtained using quantifier MRM ion transitions for individual analytes as 
follows: Diethyl-noradrenaline 226>179, monoethyl-adrenaline 212>194, diethyl-dopamine 
210>137, diethyl-normetanephrine 240>207, monoethyl-metanephrine 208>193, and diethyl-3-
methoxytyramine  224>151. 
An Atlantis T3 HPLC column (150 x 2.1 mm; Waters) was used to separate the biogenic amine 





















Adrenaline  29 nmol/L  
(N-ethyl derivative) 
Noradrenaline  173 nmol/L  
(N-diethyl derivative) 
Free metanephrine  50 nmol/L  
(N-ethyl derivative) 
Dopamine  633  nmol/L  
(N-diethyl derivative) 
Free normetanephrine  110  nmol/L  
(N-diethyl derivative) 








DILUTE, DERIVATISE AND SHOOT:  MEASUREMENT OF URINARY FREE METANEPHRINES AND 
CATECHOLAMINES AS ETHYL DERIVATIVES BY LC-MSMS 
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• A simple and rapid method has been used to convert urinary free catecholamines and 
metanephrines to ethyl derivatives prior to LC-MSMS. 
• Ethylation improved the sensitivity of measurement of the biogenic amines to allow a 
direct ‘dilute, derivatise and shoot’ approach without solid-phase extraction of urine 
prior to analysis. 
• Reverse-phase chromatography also was improved with greater retention of derivatised 
biogenic amines on the HPLC column. 
• Gender-related ranges for free urine metanephrines were determined in early morning 
spot urines collected from a group of 198 adult patients. 
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